MALE
REPRODUCTIVE ORGANS
A. The
male reproductive organs are classified as
1. Essential
organs – gonads of the male; testes
2. Accessory
organ of reproduction:
a. Genital
ducts convey sperm to outside of the body; pair of epididymis, paired vas
deferentia, pair of ejaculatory ducts and urethra.
b. Accessory
glands produce secretions that nourish, transport and mature sperm; pair of
seminal vesicles, the prostate and pair of bulbourethral glands
B. The
perineum in males is roughly diamond–shaped area between thighs; extends
anteriorly from symphysis pubis to coccyx posteriorly; lateral boundary is the
ischial tuberosity on either side; divided into the urogenital triangle and the
anal triangle.
The Testes
A.
Structures and
location
1. Several
lobules composed of seminiferous tubules and interstitial cells of Leydig,
separated by septa, encased in fibrous capsule called tunica albuginea.
2. Seminiferous
tubules in testis open into a plexus called rete testis, which is drained by a
series of efferent ductules that emerge from the top of the organ and enter the
head of epididymis.
3. Located
in scrotum, one testis in each of two scrotal compartments.
B.
Functions
1. Spermatogenesis – formation
of mature male gametes (spermatozoa) by seminiferous tubules.
2. Secretion
of hormone (testosterone) by interstitial cells.
C.
Structure of
spermatozoa
– consists of a head (covered by acrosome), neck, midpiece and tail; tail is
divided into a principal piece and a short end–piece.
Reproductive (Genital) ducts
A. Epididymis
1.
Structure and
location
a. Single
tightly coiled tube enclosed in fibrous casting
b. Lies
along top and side of each testes
c. Anatomical
divisions include head, body and tail
2.
Function
a. Duct
for seminal fluid
b. Also
secretes part of seminal fluid
c. Sperm
becomes capable of motility while they are passing through the epididymis
B. Vas
deferens (ductus deferens)
1.
Structure and
location
a. Tube,
extension of epididymis
b. Extends
through inguinal canal, into abdominal cavity, over top and down posterior
surface of bladder.
c. Enlarged
terminal portion called ampulla – joins duct of seminal vesicle.
2.
Function
a. One
of excretory ducts for seminal fluid
b. Connects
epididymis with ejaculatory duct
C. Ejaculatory
duct
1. Formed
by union of vas deferens with duct from seminal vesicle
2. Passes
through prostate gland, terminating in urethra
****** ACCESSORY REPRODUCTIVE GLANDS ******
A.
Seminal
vesicles
1. Structure
and location – convoluted pouches on posterior surface of bladder.
2. Function
– secrete the viscous nutrient–rich part of seminal fluid (60%)
B.
Prostate gland
1. Structure
and location
a. Doughnut–shaped
b. Encircles
urethra just below bladder
2. Function
– adds alkaline secretion to seminal fluid (30%)
C.
Bulbourethral
gland
1. Structure
and location
a. Small,
pea–shaped structures with 1–inch long ducts leading into urethra
b. Lie
below prostate gland
2. Function
– secrete alkaline fluid that is part of the semen (5%)
Supporting structures
A.
Scrotum
1. Skin
covered pouch suspended from perineal region
2. Divided
into two compartments
3. Contains
testis, epididymis and lower part of spematic cord.
4. Dartos
and cremaster muscles elevate the scrotal pouch.
B.
Penis
1. Structure
– composed of three cylindrical masses of erectile tissue, one of which
contains urethra.
2. Function
– penis contains urethra, the terminal duct for both urinary and reproductive
tracts; during sexual intercourse, penis becomes erect, serving as penetrating
copulatory organ during sexual intercourse.
C.
Spermatic cord
(internal)
1. Fibrous
cylinders located in inguinal canals.
2. Enclose
seminal ducts, blood vessels, lymphatics and nerves
Regulation of secretion of
testicular hormones
1.
Long–loop
feedback control system
a. The
hypothalamus secretes gonadotropin–releasing hormone (Gn–RH).
b. After
reaching the pituitary via the hypophyseal portal system, the Gn– RH attaches
to receptors on the gonadotropes in the anterior pituitary.
c. Adenylate
cyclase is stimulated, causing the formation of cAMP, which promotes the entry
of calcium into the cells. By this process, the secretion of the glycoproteins
luteinizing hormone (LH), previously known as interstitial cell–stimulating
hormone (ICSH) and FSH is enhanced.
d. Pituitary
secretion of LH stimulates the Leydig cells of the testis to produce testosterone
and estradiol. Membranes of these cells contain specific protein receptors for
LH. The binding of LH to the receptor causes an increase in cAMP and protein
kinase activity.
e. The
metabolic sequence results in an increase in the synthesis of prenenolone and
then testosterone, the principal androgen of the testis, and also small amount
of estradiol. Some of the testosterone produced is delivered to the
seminiferous tubules, where it acts on Sertoli cells to stimulate
spermatogenesis and some enters the blood stream.
f.
Testosterone or its metabolite
inhibit the release of Gn–RH from the hypothalamus and inhibit the actions of
Gn–RH at the anterior pituitary level. These sites have high affinity receptors
for testosterone and its metabolites, but testosterone seems to be much more
important than estradiol in providing the negative feedback regulation.
g. FSH
activates adenylate cyclase in the Sertoli cells, which consequently causes the
aromatization of testosterone to estradiol. Sertoli cells cannot synthesize
testosterone from cholesterol since they do not possess the necessary enzymes.
h. The
testosterone found in the cells is the result of diffusion from the
interstitial cells of Leydig.
i.
FSH appears necessary only for
the initial wave of spermatogenesis that occurs during puberty and is not
necessary in the maintenance of spermatogenesis. The negative feedback
mechanism of FSH appears to be by inhibin.
j.
Inhibin is a peptide that is
synthesized within the Sertoli cells, which can inhibit the release of FSH at
the pituitary level as well as at the hypothalamus level to limit Gn–RH
secretion.
2.
Short–loop
feedback control system
a. The
Leydig cell provides adrenocorticotropic hormone / melanocyte– stimulating hormone
(ACTH / MSH) peptides, which stimulate Sertoli cell function.
b. Beta–endorphin,
also produced in the Leydig cells, has inhibitory action in the Sertoli cell.
c. On
the other hand, inhibin, which is produced by the Sertoli cell, stimulates the
Legdig cell production of the androgens and the estrogen that diffuses from the
Sertoli cells into the adjacent Leydig cells may have the ability to reduce
testosterone biosynthesis.
The Testicular Hormone
1.
Androgens
a.
Biosynthesis
and metabolism
The androgens
are steroid hormones in the C–19 group. The Leydig cells or interstitial cells
of the testis are responsible for the production of most androgens in male.
There are two major routes for the conversion of pregnenolone to testosterone.
(1) The
first route involves the production of 17–hydroxypregnenolone from pregnenolone. After that
conversion, 17–hydroxypregnenolone is converted to dehydroepiandrosterone
(DHEA) which goes to androstenediol and
finally testosterone.
(2) The
second pathway involves the production of progesterone, its conversion to 17–hydroxyprogesterone,
androstenedione and then testosterone. This pathway is referred to as 4–ene
pathway, referring to the double bond between carbons 4 and 5. The enzymes for
both of these pathways are located in the smooth endoplasmic reticulum of the
cell.
2.
Testosterone
Testosterone
is not stored in the testis. Once it is synthesized, it is secreted into the
blood, where 97% circulates bound to plasma proteins. These plasma
proteins are albumin, transcortin and testosterone binding globulin (TeBG).
TeBG has a relatively high affinity for androgens, and approximately 56% of the
total bound testosterone is carried by TeBG. The small amount of the free
hormone (3%) is responsible for the biologic response since only free hormone
can enter target cells. The catabolism of androgens, as with most steroid
occurs in the liver with subsequent excretion by the kidney. The principal
products of testosterone metabolism are:
a. Androsterone
b. Etiocholalone
Laboratory evaluation of
testicular function
1. 17–hydroxykorticosteroid
2. Semen
analysis
3. Chorionic
Gonadotropin Stimulation test (hCG)
hCG has the
same biologic action as LH, so following an injection of hCG, this hormone will
bind to the LH receptors on the Leydig cells and stimulates the synthesis and
secretion of testicular steroids. Therefore, the Leydig cells may be directly
assessed.
4. Clomiphene
Citrate Stimulation Test
Clomiphene
citrate is a non–steroid compound with weak estrogenic activity. It binds to
estrogen receptors in various tissues, including the hypothalamus. By
preventing the more potent estrogen estradiol from occupying these receptors,
the hypothalamus in effect “sees” less estradiol.
5. Gonadotropoin–Releasing
Hormone Test
GnRH administered
by repeated injections every 60–120 minutes or by a programmable pulsatile
infusion pump for 7–14 days, patients with hypothalamic lesions may have their
pituitary responsiveness to GnRH restored, whereas patients with pituitary
insufficiency do not.
6. Testicular
biopsy
Clinical significance of
testicular function
1.
Male
infertility
a.
Pre–testicular
causes
– usually from hypothalamic or pituitary lesions, leading to the decreased
production of the gonadotropins.
(1) Hypothyroidism
(2) Cushing’s
syndrome
(3) Malnutrition
(4) Alcoholic
cirrhosis
b.
Testicular
causes
(1) Congenital
disorders
(a) Cryptochordism
is unilateral or bilateral absence of the testes from the scrotum because of
failure of normal testicular descent from the genital ridge through the
external inguinal ring.
(b) Klinefelter’s
syndrome – XXY seminiferous tubule dysgenesis
(2) Acquired
disorders
(a) Germ
cell tumor
(b) Leydig
cell tumor
(c) Varicocele
(d) Orchitis
c.
Post–testicular
causes
(1) Mechanical
impairment of transport due to
(a) Defect
of male reproductive tract
(2) Functional
impairment of sperm transport due to
(a) Autonomic
nervous system impairment
(b) Bladder
neck incompetence
(c) Production
of sperm antibodies
2.
Syndromes of
androgen resistance
– results from a single gene mutation causing the affected person to be
affected resistant to androgen action.
a.
5–alpha–reductase
deficiency
– deficient conversion of testosterone to dihydrotestosterone. The patient is a
genotypic 46, XY male with normal levels of testosterone but demonstrates
predominantly female external genitalia. These individuals are raised as girls
but at puberty exhibit virilization.
b.
Defective
androgen receptor
(1)
Reifenstein
syndrome
– partial resistance to the action of testosterone and dihydrostestosterone in
X linked disorder.
(2)
Infertile male
syndrome
– normal males with infertility due to azoospermia or severe oligospermia
c.
Receptor–positive resistance
was postulated as a defect after a family was found to have testicular
feminization due to androgen resistance.
3.
Impotence implies erectile dysfunction with or without
associated disturbances of libido or ejaculatory ability.
No comments:
Post a Comment